Process for the preparation of (2-methyl-1-(3-methylbenzyl)-1h-benzo[d]imidazol-5-yl)(piperidin-5-yl)methanone
A technology of methylbenzyl and piperidine, which is applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, organic active ingredients, etc., can solve the problems of not being suitable for mass production and low overall yield, and reduce the total quantity , cost reduction effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0056] [Example 1] Preparation of a compound represented by Chemical Formula 2-1
[0057] Preparation of compounds represented by chemical formula 3
[0058] 1,1'-carbonyldiimidazole (4.22 g, 26.04 mmol) was dissolved in 50 mL of ethyl acetate, and 4-chloro-3-nitrobenzoic acid (Formula 4, 5.00 g, 24.80 mmol) and stirred for 1 hour. Piperidine (2.7mL, 27.3mmol) was slowly added thereto and stirred at room temperature for 1 hour, then, the resulting mixture was sequentially washed with 6N hydrochloric acid solution (30mL, twice), saturated aqueous sodium bicarbonate (50mL), distilled water (50mL) and brine (50 mL). The organic layer was dried over anhydrous sodium sulfate (20 g) and concentrated under reduced pressure to obtain the compound represented by Chemical Formula 3 (6.39 g, 95%) as a yellow crystalline solid.
[0059] 1 H NMR (600MHz, chloroform-d 1 )δ=7.92(d, J=2.4Hz, 1H), 7.60(d, J=8.4Hz, 1H), 7.56(dd, J 1 =8.1Hz,J 2 =2.1Hz, 1H), 3.71(br, 2H), 3.35(br, 2H), 1....
Embodiment 2
[0065] [Example 2] Preparation of amine compound represented by Chemical Formula 2-2
[0066] Iron (2.85 g, 51.0 mmol) and 1.5 mL of acetic acid were added to a mixed solvent of ethanol and water (5:2, 28 mL) and stirred at 120° C. for 2 hours. After cooling to room temperature, the compound represented by Chemical Formula 2-1 (3.00 g, 8.49 mmol) was added thereto, and a mixed solvent of ethanol and water (5:2, 14 mL) was added thereto again. The reaction mixture was stirred at 110° C. for 1 hour and while it was still hot was filtered using celite under reduced pressure and washed with hot ethanol. The filtrate was concentrated and 2N aqueous sodium hydroxide was added until the pH was 8 or greater. Then, the resulting reaction mixture was extracted with ethyl acetate (50 mL, twice). The organic layer was collected, washed with saturated sodium carbonate solution (20 mL, twice), distilled water (30 mL, twice) and brine (30 mL) and dried over anhydrous sodium sulfate, then c...
Embodiment 3
[0069] [Example 3] Preparation of the compound represented by Chemical Formula 1
[0070]The amine compound represented by Chemical Formula 2-2 (2.74 g, 8.48 mmol) obtained in Example 2 was added to acetic acid (16 mL) and triethyl orthoacetate (4.6 mL, 25.1 mol) and stirred under reflux for 2 hours . The reaction mixture was concentrated under reduced pressure and diluted with ethyl acetate (50 mL). Then, a saturated sodium carbonate solution was added thereto until the pH was 8 or more, and the organic layer was separated through a separatory funnel. The organic layer was washed with distilled water (40 mL) and brine (40 mL), dried over anhydrous sodium sulfate, then filtered and concentrated under reduced pressure to obtain a yellow solid (2.75 g). The solid was recrystallized with 3 mL of ethyl acetate to obtain the compound represented by Chemical Formula 1 (2.23 g, 76%) as a white solid.
[0071] 1 H NMR (600MHz, chloroform-d 1 )δ=7.74(t, J=0.6Hz, 1H), 7.30(dd, J 1...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
![Process for the preparation of (2-methyl-1-(3-methylbenzyl)-1h-benzo[d]imidazol-5-yl)(piperidin-5-yl)methanone](https://images-eureka.patsnap.com/patent_img/8aa9b40b-4571-4ae6-bf72-1e27afbfcd08/BDA0000745827430000011.png)
![Process for the preparation of (2-methyl-1-(3-methylbenzyl)-1h-benzo[d]imidazol-5-yl)(piperidin-5-yl)methanone](https://images-eureka.patsnap.com/patent_img/8aa9b40b-4571-4ae6-bf72-1e27afbfcd08/BDA0000745827430000012.png)
![Process for the preparation of (2-methyl-1-(3-methylbenzyl)-1h-benzo[d]imidazol-5-yl)(piperidin-5-yl)methanone](https://images-eureka.patsnap.com/patent_img/8aa9b40b-4571-4ae6-bf72-1e27afbfcd08/BDA0000745827430000021.png)